“american-society-of-clinical-oncology” Archives

in
Entry Author Date Location
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Mirati Stock Sale Targets $200M as Lead Cancer Drug Starts Phase 3 06/26/19 San Diego
Oncternal Therapeutics Goes Public After Reverse Merger With GTx 06/12/19 San Diego
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition 01/07/19 Indiana
BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage 12/04/18 National
FDA Puts Mersana Cancer Study on Partial Hold After Patient Death 07/19/18 Boston
ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More 06/05/18 National
Loxo Unveils More Data, Paves a Path Forward In Precision Oncology 06/02/18 National
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down 05/31/18 National
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo 05/23/18 New York
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
BioCryst, Idera Plan Merger in Tie-Up of Rare Disease Drug Developers 01/22/18 Raleigh Durham
Exact, Spectrum, PerBlue, & More: This Week’s Wisconsin Watchlist 01/19/18 Wisconsin
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push 03/30/16 Texas
Medical Test Validity Will Be Debated In 2016: 5 Storylines To Watch 01/14/16 Wisconsin
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Page 1 of 5 next page »